文献速递胸部妇产影像外周血管CTPET

妊娠及产后肺栓塞:16年CT肺动脉造影与肺闪烁显像趋势

Pulmonary embolism in pregnancy and the postpartum period: 16-Year trends in CT pulmonary angiography and lung scintigraphy.
PubMed 文献 · Eur J Radiol · 2026-10-09

该研究回顾性分析2008至2024年间妊娠及产后≤6周疑似肺栓塞患者行CTPA或LS的16年趋势。共1140例检查中,妊娠期以LS为主(65.5%),产后以CTPA为主(83.1%),CTPA使用增加而LS下降。诊断率低(妊娠期LS 2.6%、CTPA 3.7%;产后LS 0%、CTPA 6.8%),CTPA孕妇有效剂量和乳腺吸收剂量均高于LS。

要点

  • 妊娠期疑似肺栓塞影像选择从LS向CTPA转移,但CTPA乳腺吸收剂量更高。
  • 妊娠期和产后肺栓塞诊断率均低,符合排除性人群预期。
  • 产后CTPA使用率远高于妊娠期,诊断率也较高(6.8%)。

诊断标准与关键数值

  • 妊娠期肺栓塞检出率:LS 16/619(2.6%),CTPA 12/326(3.7%)。
  • 产后肺栓塞检出率:LS 0/33(0%),CTPA 11/162(6.8%)。
  • 妊娠期孕妇有效剂量中位数:LS 0.544 mSv(IQR 0.512-0.593,n=449),CTPA 2.96 mSv(IQR 2.23-3.74,n=305)。
  • 产后孕妇有效剂量中位数:LS 1.126 mSv(IQR 1.045-1.243,n=10),CTPA 1.69 mSv(IQR 1.43-2.42,n=142)。
  • 妊娠期和产后CTPA乳腺吸收剂量均高于LS(均p < 0.001)。

临床应用与阅片要点

  • 妊娠期疑似肺栓塞可优先考虑LS以降低乳腺吸收剂量,但需结合临床和影像可及性。
  • 产后患者CTPA使用率高且诊断率相对较高,但仍需注意低诊断率下的合理选择。
  • 报告时应关注CTPA和LS的剂量差异,尤其妊娠期乳腺剂量。

局限性

  • 回顾性单中心研究设计可能引入选择偏倚。
  • 部分剂量分析样本量较小(如产后LS n=10)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate 16-year trends in utilisation, radiation exposure, and diagnostic yield of computed tomography pulmonary angiography (CTPA) and lung scintigraphy (LS) for suspected pulmonary embolism (PE) during pregnancy and postpartum period.

MATERIALS AND METHODS: Pregnant and ≤ 6-week postpartum patients undergoing CTPA or LS from 2008 to 2024 were retrospectively studied. CTPA maternal effective, breast absorbed and modelled foetal effective doses were estimated using Monte Carlo modelling. LS maternal effective, breast absorbed and foetal absorbed doses were calculated from administered activity using ICRP coefficients.

RESULTS: Of 1,140 imaging examinations, 945 occurred during pregnancy (619 LS; 326 CTPA) and 195 postpartum (33 LS; 162 CTPA). LS comprised 65.5% of pregnancy examinations but 16.9% postpartum compared with 34.5% and 83.1% for CTPA respectively (p < 0.001). CTPA use increased while LS use declined. During pregnancy, PE was detected in 16/619 LS examinations (2.6%) and 12/326 CTPAs (3.7%); postpartum, in 0/33 LS examinations and 11/162 CTPAs (6.8%). Median maternal effective doses during pregnancy were 0.544 mSv for LS (IQR 0.512-0.593, n = 449) and 2.96 mSv for CTPA (IQR 2.23-3.74, n = 305); postpartum effective doses were 1.126 mSv (IQR1.045-1.243, n = 10) and 1.69 mSv (IQR 1.43-2.42, n = 142), respectively. Breast absorbed dose was higher with CTPA during pregnancy and postpartum (both p < 0.001).

CONCLUSION: Over 16 years, imaging shifted from LS towards CTPA. Diagnostic yield remained low, as expected in a rule-out population, while CTPA was associated with higher maternal effective and breast absorbed doses than LS. These findings underscore the importance of appropriate imaging selection in this population.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Kakish E, Lee RJ, Kock L, et al. Pulmonary embolism in pregnancy and the postpartum period: 16-Year trends in CT pulmonary angiography and lung scintigraphy. Eur J Radiol. 2026. PMID: 42887437. doi:10.1016/j.ejrad.2026.113300

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。